Vistagen reports Phase 2 repeat dose results for fasedienol in SAD

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. META
2. OKTA
3. ORCL
4. SPY
5. P
6. MCD
7. MGM
8. NVDA
9. ACAD
10. GDDY

Go back to Vistagen reports Phase 2 repeat dose results for fasedienol in SAD
(NASDAQ: VTGN) Delayed: 0.30 -0.07 (18.92%)
Previous Close $0.37    52 Week High $4.60 
Open $0.35    52 Week Low $2.81 
Day High $0.36    P/E N/A 
Day Low $0.27    EPS $0.00 
Volume 17,952,462